VM
VHCP Management Portfolio holdings
AUM
$93M
This Quarter Return
+72.42%
1 Year Return
-10.46%
3 Year Return
+232.85%
5 Year Return
–
10 Year Return
–
AUM
$181M
AUM Growth
+$181M
(+34%)
Cap. Flow
+$3.74M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
86%
Holding
20
New
3
Increased
1
Reduced
4
Closed
2
Top Buys
1 |
BioCryst Pharmaceuticals
BCRX
|
$8.5M |
2 |
Heron Therapeutics
HRTX
|
$3.04M |
3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$1.56M |
Top Sells
1 |
Neurocrine Biosciences
NBIX
|
$7.85M |
2 |
Vanda Pharmaceuticals
VNDA
|
$3.25M |
3 |
STML
Stemline Therapeutics, Inc.
STML
|
$1.19M |
4 |
HPTX
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
|
$978K |
5 |
ANTH
Anthera Pharmaceuticals, Inc.
ANTH
|
$666K |
Sector Composition
1 | Healthcare | 63.57% |